 SALT LAKE CITY, July 14, 2021 GLOBE NEWSWIRE -- Sera Prognostics Inc., The Pregnancy Company Sera, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of 16.00 per share. The gross proceeds to Sera from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be approximately 75.0 million. The shares are expected to begin trading on the Nasdaq Global Market on July 15, 2021 under the symbol SERA. The offering is expected to close on July 19, 2021, subject to customary closing conditions. In addition, Sera has granted the underwriters a 30-day option to purchase up to an additional 703,125 shares of common stock at the initial price to the public less underwriting discounts. 